Breaking News

Frontage to Acquire Quintara Discovery

Quintara provides in vitro ADME profiling, bioanalytical services, and dedicated assay development and compound screening.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Global contract research organization (CRO) Frontage Laboratories has entered into a deal to acquire Quintara Discovery, a drug discovery and development specialist based in the San Francisco Bay Area.   Established in 2013, Quintara provides in vitro ADME profiling, bioanalytical services, and dedicated assay development and compound screening.   “Quintara has an exceptional discovery and development platform that it has leveraged to build a strong reputation with its clients,” said Accor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters